BBH vs. GNOM
Compare and contrast key facts about VanEck Vectors Biotech ETF (BBH) and Global X Genomics & Biotechnology ETF (GNOM).
BBH and GNOM are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. GNOM is a passively managed fund by Global X that tracks the performance of the Solactive Genomics Index. It was launched on Apr 5, 2019. Both BBH and GNOM are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BBH vs. GNOM - Performance Comparison
Loading graphics...
BBH vs. GNOM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.04% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 6.33% |
GNOM Global X Genomics & Biotechnology ETF | -2.79% | 18.65% | -15.99% | -8.63% | -36.27% | -15.93% | 51.52% | 1.56% |
Returns By Period
In the year-to-date period, BBH achieves a 0.04% return, which is significantly higher than GNOM's -2.79% return.
BBH
- 1D
- 0.70%
- 1M
- -3.58%
- YTD
- 0.04%
- 6M
- 10.55%
- 1Y
- 23.57%
- 3Y*
- 5.92%
- 5Y*
- 1.84%
- 10Y*
- 6.42%
GNOM
- 1D
- 1.02%
- 1M
- -6.22%
- YTD
- -2.79%
- 6M
- 12.23%
- 1Y
- 44.15%
- 3Y*
- -3.13%
- 5Y*
- -13.13%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBH vs. GNOM - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is lower than GNOM's 0.50% expense ratio.
Return for Risk
BBH vs. GNOM — Risk / Return Rank
BBH
GNOM
BBH vs. GNOM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | GNOM | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.05 | 1.43 | -0.38 |
Sortino ratioReturn per unit of downside risk | 1.53 | 2.04 | -0.51 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.26 | -0.06 |
Calmar ratioReturn relative to maximum drawdown | 2.00 | 2.25 | -0.25 |
Martin ratioReturn relative to average drawdown | 5.56 | 7.43 | -1.86 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BBH | GNOM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.05 | 1.43 | -0.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.09 | -0.39 | +0.48 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | -0.13 | +0.40 |
Correlation
The correlation between BBH and GNOM is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
BBH vs. GNOM - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.51%, less than GNOM's 1.41% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
GNOM Global X Genomics & Biotechnology ETF | 1.41% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BBH vs. GNOM - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, roughly equal to the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for BBH and GNOM.
Loading graphics...
Drawdown Indicators
| BBH | GNOM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -75.00% | +2.30% |
Max Drawdown (1Y)Largest decline over 1 year | -10.47% | -18.17% | +7.70% |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | -72.29% | +32.43% |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | — | — |
Current DrawdownCurrent decline from peak | -12.15% | -59.83% | +47.68% |
Average DrawdownAverage peak-to-trough decline | -26.05% | -40.12% | +14.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.76% | 5.51% | -1.75% |
Volatility
BBH vs. GNOM - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 7.01%, while Global X Genomics & Biotechnology ETF (GNOM) has a volatility of 10.76%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than GNOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BBH | GNOM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.01% | 10.76% | -3.75% |
Volatility (6M)Calculated over the trailing 6-month period | 13.69% | 19.71% | -6.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.72% | 31.21% | -8.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.47% | 33.65% | -12.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.27% | 34.30% | -12.03% |